Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
10
2015
Bottoms Up: Pennsylvania Liquor Control Board Permits 12-Pack Beer Sales at Beer Distributors Morgan, Lewis & Bockius LLP
Mar
10
2015
3-D Printing Guidance Only a B-List Priority for FDA Epstein Becker & Green, P.C.
Mar
10
2015
The Remicade Biosimilar Patent Dispute Foley & Lardner LLP
Mar
9
2015
D.C. District Court Dismisses Country of Origin Labeling Lawsuit Varnum LLP
Mar
9
2015
Protective Order Issued in Suit to Stop EPA from Releasing Farmers’ Information Varnum LLP
Mar
9
2015
Novartis Wins Landmark Biosimilar Approval Schwegman, Lundberg & Woessner, P.A.
Mar
9
2015
Must Gluten-free Be Free? What You Should Know About Celiac Disease and the ADA McBrayer, McGinnis, Leslie and Kirkland, PLLC
Mar
9
2015
U.S. FDA Approves the First Biosimilar Product Michael Best & Friedrich LLP
Mar
8
2015
New Rule Ahead for Farm Animal Antibiotics Varnum LLP
Mar
8
2015
Lawsuits Against Endoscope Manufacturers and Health Care Facilities to Increase Following UCLA’s “Superbug” Outbreak Armstrong Teasdale
Mar
6
2015
Company Pays For Taking Short Cuts to Start New Business Jackson Lewis P.C.
Mar
6
2015
And the Beat Goes On: NY State Assembly to Vote on GMO Labeling Law Mintz
Mar
5
2015
STRONG Patents Act Would Fix Micro Entity Gap Foley & Lardner LLP
Mar
5
2015
SEC Enforcement Director Discusses Issues for Pharmaceutical and Medical Technology Companies Mintz
Mar
5
2015
The Apotex Case: Current Good Manufacturing Practices (cGMP) violations Mahany Law
Mar
4
2015
Ascertainability Saps Plaintiffs’ Energy in Dietary Supplement Class Action Sheppard, Mullin, Richter & Hampton LLP
Mar
4
2015
Still Waiting for ADA and GINA Guidance on Wellness Incentives Jackson Lewis P.C.
Mar
3
2015
No Longer at Lager-Heads: Anheuser-Busch Settles Claim over Kirin Beer’s Origin Proskauer Rose LLP
Mar
3
2015
APHIS Withdraws 2008 Proposal to Amend Regulation of GE Organisms: Animal and Plant Health Inspection Service Beveridge & Diamond PC
Mar
3
2015
Third Circuit Affirms MillerCoors Victory in Wholesaler Contract Dispute McDermott Will & Emery
Mar
3
2015
Details Of The European Commission’s Legal Analysis Of ‘Reverse Patent Settlement Agreements’ Revealed Covington & Burling LLP
Mar
2
2015
Drones May Soon Take Off in Agriculture Industry Barnes & Thornburg LLP
Mar
2
2015
Federal Circuit Upholds Patent Term Adjustment Deduction For IDS Filed After Restriction Requirement Foley & Lardner LLP
Mar
2
2015
NASDA Supports National Uniform Labeling Policy for Genetically Modified Foods --National Association of State Departments of Agriculture Varnum LLP
Mar
1
2015
A Second Look At The Innovation Act Obviousness Type Double Patenting Statute Foley & Lardner LLP
Feb
27
2015
Grants Available for Specialty Crops – March 26 Deadline Varnum LLP
Feb
27
2015
FDA Proposal to Regulate Laboratory Developed Tests Raises Legal Liability Questions for Labs Covington & Burling LLP
Feb
27
2015
FTC to Accelerate Oncology Drug Growth, Requires Novartis to Divest Two Protein Inhibitors in Its Clinical Development Pipeline Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins